1-5 of 5
Joëlle Blumberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fertility of Women Treated during Childhood with Triptorelin (Depot Formulation) for Central Precocious Puberty: The PREFER Study

Open Access
Subject Area:
Endocrinology , Women's and Children's Health
Laetitia Martinerie, Jacques de Mouzon, Joelle Blumberg, Luigi di Nicola, Pascal Maisonobe, Jean-Claude Carel, on behalf of the PREFER study group
Journal: Hormone Research in Paediatrics
Horm Res Paediatr (2021) 93 (9-10): 529–538.
https://doi.org/10.1159/000513702
Published Online: 20 April 2021
View articletitled, Fertility of Women Treated during Childhood with Triptorelin (Depot Formulation) for Central Precocious Puberty: The PREFER Study
Open the PDF for Fertility of Women Treated during Childhood with Triptorelin (Depot Formulation) for Central Precocious Puberty: The PREFER Study in another window
Journal Articles

A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate

Available to Purchase
Subject Area:
Endocrinology , Women's and Children's Health
Delphine Zenaty, Joelle Blumberg, Nilani Liyanage, Evelyne Jacqz-Aigrain, Najiba Lahlou, Jean-Claude Carel, on behalf of co-investigators
Journal: Hormone Research in Paediatrics
Horm Res Paediatr (2016) 86 (3): 188–195.
https://doi.org/10.1159/000448840
Published Online: 08 November 2016
View articletitled, A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate
Open the PDF for A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate in another window
Journal Articles

Long-Acting Lanreotide in Adolescent Girls with Constitutional Tall Stature

Available to Purchase
Subject Area:
Endocrinology , Women's and Children's Health
Jean-Claude Carel, Joëlle Blumberg, Muriel Bougeard-Julien, Pierre Rochiccioli, Jean-Louis Chaussain, Maïthé Tauber
Journal: Hormone Research in Paediatrics
Hormone Research (2009) 71 (4): 228–236.
https://doi.org/10.1159/000201112
Published Online: 04 March 2009
View articletitled, Long-Acting Lanreotide in Adolescent Girls with Constitutional Tall Stature
Open the PDF for Long-Acting Lanreotide in Adolescent Girls with Constitutional Tall Stature in another window
Journal Articles

Pharmacodynamic Equivalence of a Decapeptyl 3-Month SR Formulation with the 28-Day SR Formulation in Patients with Advanced Prostate Cancer

Available to Purchase
Subject Area:
Endocrinology , Women's and Children's Health
Pierre Teillac, Christiaan F. Heyns, Amir V. Kaisary, Olivier Bouchot, Joëlle Blumberg
Journal: Hormone Research in Paediatrics
Hormone Research (2004) 62 (5): 252–258.
https://doi.org/10.1159/000081629
Published Online: 22 November 2004
View articletitled, Pharmacodynamic Equivalence of a Decapeptyl 3-Month SR Formulation with the 28-Day SR Formulation in Patients with Advanced Prostate Cancer
Open the PDF for Pharmacodynamic Equivalence of a Decapeptyl 3-Month SR Formulation with the 28-Day SR Formulation in Patients with Advanced Prostate Cancer in another window
Journal Articles

Three-Month Sustained-Release Form of Triptorelin in Patients with Advanced Prostatic Adenocarcinoma: Results of an Open Pharmacodynamic and Pharmacokinetic Multicenter Study

Available to Purchase
Subject Area:
Endocrinology , Women's and Children's Health
Olivier Bouchot, Jean Yves Soret, Didier Jacqmin, N. Lahlou, M. Roger, Joëlle Blumberg
Journal: Hormone Research in Paediatrics
Hormone Research (1998) 50 (2): 89–93.
https://doi.org/10.1159/000023241
Published Online: 17 August 1998
View articletitled, Three-Month Sustained-Release Form of Triptorelin in Patients with Advanced Prostatic Adenocarcinoma: Results of an Open Pharmacodynamic and Pharmacokinetic Multicenter Study
Open the PDF for Three-Month Sustained-Release Form of Triptorelin in Patients with Advanced Prostatic Adenocarcinoma: Results of an Open Pharmacodynamic and Pharmacokinetic Multicenter Study in another window